Objective To investigate the effect of Ginkgo ketone ester dispersible tablets on the inflammatory
reaction and cognitive function after ischemic stroke and its clinical significance.
Methods This study was a prospective, multi-center, clinical randomized and controlled trial.
Patients with acute ischemic stroke from Neurological Department in Nanjing Drum Tower
Hospital and Yangzhou First People's Hospital during October 2012 to June 2014 were recruited
and randomly divided into therapeutic group (Ginkgo ketone ester dispersible tablets (0.15 tid)
combined with aspirin group (0.1 qd) and control group (aspirin group (0.1 qd), medication 180 d).
Fresh blood was harvested before treatment and 13±1 days after treatment from enrolled patients.
Serum inflammatory cytokines (IL-1β, IL-6, IL-15, IL-17A, IL-23 and TNF-α) were detected by
Milliplex Map multiple detection techniques. National Institutes Health Stroke Scale (NIHSS),
modified Rankin Scale (mRS), Mini-Metal State Examination (MMSE) and Montreal Cognitive
Assessment (MOCA) were applied to evaluate neurological deficits and cognitive decline before
treatment and (13±1) d, (30±7) d, (90±7) d, (180±7) d after treatment, and to compare scale scores
changes in two groups before and after treatment.
Results A total of 60 patients were enrolled into study. Among whom, 8 cases were excluded
due to non-eligible blood specimen; 27 cases of study group and 25 cases of control group were
taken into statistical analysis. Treatment of (13±1) d, the serum IL-1 beta IL-1β ([1.55±0.43] pg/
ml vs [2.05±0.74] pg/ml, P <0.001), IL-15 ([1.88±0.82] pg/ml vs [3.17±1.93] pg/ml, P <0.001), IL-6
([5.57±4.96] pg/ml vs [8.81±8.00] pg/ml, P =0.042), IL-17A ([5.11±1.51] pg/ml vs [6.67±2.24] pg/
ml, P <0.001), IL-23 ([0.42±0.88] pg/ml vs [0.67±0.98] pg/ml, P <0.001), TNF-alpha ([15.12±6.97]
pg/ml vs [18.31±6.61] pg/ml, P =0.009) levels in therapeutic group were decreased significantly
than that before treatment; while in the control group, only IL-15 ([2.01±0.72] pg/ml vs [2.53±1.20]
pg/ml, P =0.036) level was significantly decreased compared with that of before treatment. After
treatment (30±7) d, (90±7) d, (180±7) d in the therapeutic group, MMSE and MOCA scores were
improved more significantly than that before treatment compared with the control group (P =0.036,
0.012 and 0.048), though the two scores were of no significant differences in two groups.
Conclusion The combination of Ginkgo ketone ester dispersible tablets and aspirin can more
obviously reduce serum inflammatory cytokines and improve their cognitive function compared
with using aspirin alone in ischemic stroke patient.